Maravai LifeSciences Holdings, Inc. (MRVI) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 8.66M | -22.77M | -15.15M | -10.27M | -9.39M | -14.64M | 13.14M | 17.43M | -8.47M | 7.79M | 14.17M | 19.19M |
| Operating CF Margin % | 13.16% | -45.66% | -36.39% | -21.66% | -20.04% | -25.95% | 20.15% | 23.75% | -13.19% | 10.51% | 21.19% | 27.85% |
| Operating CF Growth % | 192.28% | -55.54% | -215.33% | -158.88% | -10.9% | -287.91% | -7.27% | -9.17% | -109.95% | -92.16% | -87.13% | -88.32% |
| Net Income | -3.73M | -40.11M | -25.56M | -69.84M | -29.95M | -26.14M | -172.03M | -7.58M | -12.08M | -105.96M | -6.46M | -11.94M |
| Depreciation & Amortization | 12.98M | 4.42M | 15.84M | 15.39M | 14.91M | 15.18M | 14.04M | 14.55M | 13.75M | 12.98M | 13.1M | 11.8M |
| Stock-Based Compensation | 0 | 0 | 9.06M | 6.79M | 10.4M | 10.54M | 13.05M | 13.76M | 12.06M | 0 | 9.99M | 9.27M |
| Deferred Taxes | 0 | 6K | 0 | 0 | 0 | 0 | -2.44M | 0 | 0 | 764.75M | -5.53M | -2.76M |
| Other Non-Cash Items | 5.25M | 32.35M | -21.48M | 36.26M | -10.25M | -1.41M | 158.64M | -5.53M | -11.56M | -666.36M | -5.5M | -5.73M |
| Working Capital Changes | -5.83M | -19.43M | 6.99M | 1.14M | 5.49M | -12.81M | 1.87M | 2.24M | -10.64M | 2.38M | 8.57M | 18.55M |
| Change in Receivables | -7.91M | -2.96M | 5.12M | 501K | 10.16M | -11.35M | 5.93M | -2.02M | 17.88M | -8.79M | 3.21M | 7.56M |
| Change in Inventory | 33K | 3.09M | 1.35M | 3.11M | 449K | 327K | -1.47M | 751K | 820K | -2.18M | -1.5M | 7.71M |
| Change in Payables | 6.16M | -5.51M | 0 | 1.78M | -708K | 0 | -2.42M | 4.57M | -3.68M | 1.66M | 1.99M | 1.87M |
| Cash from Investing | -4.44M | -2.11M | -2.93M | -3.24M | -23.13M | -4.93M | -8.96M | -6.18M | -4.24M | -12.9M | -15.52M | -24.16M |
| Capital Expenditures | -4.44M | -2.11M | -2.93M | -2.87M | -5.24M | -5.85M | -8.59M | -9.55M | -5.67M | -16.8M | -15.83M | -25.06M |
| CapEx % of Revenue | 6.74% | 4.24% | 7.03% | 6.06% | 11.17% | 10.37% | 13.18% | 13.01% | 8.83% | 22.66% | 23.67% | 36.36% |
| Acquisitions | 0 | 0 | 0 | -362K | -18.63M | 0 | 0 | 0 | 0 | 0 | 0 | 109K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 734K | 918K | -368K | 3.37M | 1.42M | 3.9M | 307K | 793K |
| Cash from Financing | -55.23M | -1.82M | -8.25M | -1.53M | -4.9M | -236.19M | 809K | 228K | -560K | 470K | 783K | -43.13M |
| Debt Issued (Net) | -51.36M | -790K | -1.56M | -1.55M | -1.54M | -230.49M | -1.52M | -1.51M | -1.5M | -1.5M | -1.48M | -1.43M |
| Equity Issued (Net) | 0 | 0 | 111K | 13K | -4.73M | -602K | 0 | -28K | -1.43M | -20K | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 111K | 0 | 0 | -602K | 0 | -28K | -1.43M | 0 | 0 | 0 |
| Other Financing | -3.87M | -1.03M | -6.8M | 0 | 1.38M | -5.09M | 2.33M | 1.76M | 2.38M | 1.99M | 2.27M | -41.71M |
| Net Change in Cash | -50.97M | -26.68M | -26.33M | -15.15M | -37.35M | -255.76M | 4.99M | 11.48M | -13.27M | -4.64M | -571K | -48.1M |
| Free Cash Flow | 4.23M | -24.88M | -18.08M | -13.14M | -14.63M | -20.49M | 3.54M | 7.88M | -14.13M | -9.01M | -1.66M | -5.87M |
| FCF Margin % | 6.42% | -49.9% | -43.42% | -27.72% | -31.22% | -36.32% | 5.44% | 10.74% | -22.02% | -12.15% | -2.48% | -8.51% |
| FCF Growth % | 128.91% | -21.45% | -609.9% | -266.72% | -3.49% | -127.41% | 313.43% | 234.37% | -118.3% | -109.67% | -101.6% | -103.61% |
| FCF per Share | 0.03 | -0.17 | -0.12 | -0.09 | -0.10 | -0.15 | 0.03 | 0.06 | -0.11 | -0.07 | -0.01 | -0.04 |
| FCF Conversion (FCF/Net Income) | -2.32x | 0.64x | 0.59x | 0.26x | 0.31x | 0.56x | -0.13x | -2.30x | 0.70x | -0.07x | -2.19x | -2.93x |
| Interest Paid | 0 | 0 | 6.13M | 6.12M | 6.52M | 15.11M | 11.86M | 11.87M | 12.14M | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 139K | 0 | 267K | 180K | 197K | 0 | 0 | 0 |